This delivered miR-145 and miR-124 notably decreased the migration of glioma cells by targeting Synaptonemal Complex Protein 1 (SCP-1) and SRY-Box Transcription Factor 2 (Sox2) genes. Here, SOX2 is linked to central nervous system cancer.